【摘 要】
:
Renal cell carcinoma (RCC) is an important contributor to cancer-specific mortality worldwide. Targeted agents that inhibit key subtype-specific signaling pathw
【机 构】
:
DepartmentsofPathologyandtheDavidH.KochCenterforAppliedResearchofGenitourinaryCancers,DepartmentsofG